PharMerica Corporation  

(Public, NYSE:PMC)   Watch this stock  
Find more results for PMC
-0.78 (-2.87%)
Feb 5 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 26.29 - 27.17
52 week 23.41 - 36.96
Open 27.17
Vol / Avg. 315,715.00/300,834.00
Mkt cap 827.46M
P/E 44.96
Div/yield     -
EPS 0.59
Shares 30.45M
Beta 0.75
Inst. own 96%
Feb 29, 2016
Q4 2015 PharMerica Corp Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Nov 10, 2015
PharMerica Corp at Credit Suisse Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin 0.60% 0.36%
Operating margin 1.70% 1.38%
EBITD margin - 6.51%
Return on average assets 1.14% 0.69%
Return on average equity 2.43% 1.45%
Employees 4,800 -
CDP Score - -


1901 Campus Pl
LOUISVILLE, KY 40299-2308
United States - Map
+1-502-6277000 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


PharMerica Corporation is an institutional pharmacy services company. The Company has three operating segments: institutional pharmacy, specialty infusion services and specialty oncology pharmacy. The Company's core business institutional pharmacy segment provides pharmacy products and services to residents and patients in skilled nursing facilities, nursing centers, assisted living facilities, hospitals and other long-term alternative care settings. The Company's specialty infusion services segment provides specialty infusion services focused on providing pharmaceutical products and clinical services to patients in client facilities, hospice and outside of hospital or nursing home settings. The Company's specialty oncology pharmacy segment provides dispensing of oncology drugs, care management and other related services to patients, oncology practices and hospitals.

Officers and directors

Geoffrey G. Meyers Independent Chairman of the Board
Age: 70
Bio & Compensation  - Reuters
Gregory S. Weishar Chief Executive Officer, Director
Age: 60
Bio & Compensation  - Reuters
David W. Froesel Jr. Chief Financial Officer, Executive Vice President, Treasurer
Age: 63
Bio & Compensation  - Reuters
Suresh Vishnubhatla Executive Vice President - Long-term Care Operations
Age: 46
Bio & Compensation  - Reuters
Berard E. Tomassetti Senior Vice President, Chief Accounting Officer
Age: 59
Bio & Compensation  - Reuters
Thomas A. Caneris Senior Vice President, Chief Compliance Officer, General Counsel, Secretary
Age: 52
Bio & Compensation  - Reuters
Mark R. Lindemoen Senior Vice President - Sales and Client Services
Age: 48
Bio & Compensation  - Reuters
Robert A. McKay Senior Vice President - Purchasing and Trade Relations
Age: 53
Bio & Compensation  - Reuters
Frank E. Collins Esq. Independent Director
Age: 61
Bio & Compensation  - Reuters
W. Robert Robert Dahl Jr Independent Director
Age: 57
Bio & Compensation  - Reuters